Baird Medical Investment Holdings Ltd

Aktienanalyse zu Baird Medical Investment Holdings Ltd (BDMD)

$0.109

-0.007 (-6.75%)Zum Schluss

Loading chart…
Hoch
0.115
Eröffnung
0.095
Volumengewichteter Durchschnittskurs
0.11
Volumen
5.85M
Marktkap.
—
Tief
0.095
Umsatz
620.79K
EV/EBITDA, TTM
3.37

Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.

ir.bairdmed.com

KI-Analyse of Baird Medical Investment Holdings Ltd (BDMD)

Verkaufen

Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Baird Medical Investment Holdings Ltd (BDMD) beträgt 0.99, verglichen mit dem 5-Jahres-Durchschnitt von 0.98.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
0.98
Aktuelles P/E
0.99
Überbewertet
3.57
Unterbewertet
-1.61

Erwartetes EV/EBITDA

Überbewertet
5J-Durchschnitt EV/EBITDA
0.85
Aktuelles EV/EBITDA
3.37
Überbewertet
3.35
Unterbewertet
-1.65

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.10
Aktuelles P/S
0.12
Überbewertet
0.36
Unterbewertet
-0.17

Alphio-AI-Kursszenarien für BDMD

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%BDMD

$3.34

Szenariopreis

B

Basis

Basis · 50%BDMD

$2.78

Szenariopreis

B

Bärisch

Bärisch · 25%BDMD

$2.49

Szenariopreis

Event-Zeitleiste

2026-11-04 (ET)

18:30:00

Baird Medical Monitors Ordinary Share Price Volatility

2026-11-02 (ET)

09:30:00

Baird Medical Enters Exclusive Distribution Agreement with China Resources Medical Devices

2026-10-19 (ET)

09:31:00

Baird Medical Announces Additional Medical Device Registrations in Vietnam

2026-08-20 (ET)

09:30:00

Baird Medical Receives Product Registrations in Pakistan

2026-08-10 (ET)

09:00:00

Baird Medical and Tianjin Yuanshan Medical Sign Strategic Cooperation Agreement

News

BDMD FAQ – beantwortet von Alphio AI

Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.

Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.

Community

Mehr ↗
Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln